RXRX R&D to Revenue
Recursion Pharmaceuticals Inc Clas · R&D to Revenue
RXRX R&D to Revenue
Latest reported569.45%period ending
RXRX FY R&D/Revenue (2677.32% → 569.45%)
Latest values, visible window
High-resolution chart · PNG
RXRX r&d to revenue history
Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D to Revenue |
|---|---|
| 569.4487% | |
| 534.3752% | |
| 549.7903% | |
| 392.3691% | |
| 1,352.71% | |
| 1,855.23% | |
| 2,677.3232% |